Cargando…

Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming

Ezrin, one of the ezrin‐radixin‐moesin (ERM) proteins, is involved in the formation of cell membrane processes and has been implicated in the promotion of cancer proliferation and metastasis. However, the possible role of ezrin in hepatocellular carcinoma (HCC) metastasis and glycolysis reprogrammin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xinyue, Li, Nan, Han, Anna, Wang, Yixuan, Lin, Zhenhua, Yang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648033/ https://www.ncbi.nlm.nih.gov/pubmed/32639665 http://dx.doi.org/10.1111/cas.14562

Ejemplares similares

Ezrin promotes breast cancer progression by modulating AKT signals
por: Li, Nan, et al.
Publicado: (2019)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

The CPT1A/Snail axis promotes pancreatic adenocarcinoma progression and metastasis by activating the glycolytic pathway
por: Yang, Shipeng, et al.
Publicado: (2023)

Celastrol inhibits ezrin-mediated migration of hepatocellular carcinoma cells
por: Du, Shihao, et al.
Publicado: (2020)

Ezrin Is Associated with Disease Progression in Ovarian Carcinoma
por: Horwitz, Vered, et al.
Publicado: (2016)

Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2009)

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition
por: Kong, Jienan, et al.
Publicado: (2016)

Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer
por: Jin, Tiefeng, et al.
Publicado: (2014)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
por: Ma, Lijuan, et al.
Publicado: (2023)

Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis
por: Jo, Min-Sik, et al.
Publicado: (2023)

Early glycolytic reprogramming controls microglial inflammatory activation
por: Cheng, Junjie, et al.
Publicado: (2021)

Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
por: Jiang, Jianwen, et al.
Publicado: (2020)

Glycolytic reprogramming in macrophages and MSCs during inflammation
por: Li, Xueping, et al.
Publicado: (2023)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma
por: Jung, Joann, et al.
Publicado: (2022)

CircGLIS3 Promotes High-Grade Glioma Invasion via Modulating Ezrin Phosphorylation
por: Li, Yan, et al.
Publicado: (2021)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

ACLY-induced reprogramming of glycolytic metabolism plays an important role in the progression of breast cancer: Role of ACLY in breast cancer
por: Lu, Yu, et al.
Publicado: (2023)

The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice
por: Zhang, Yannan, et al.
Publicado: (2023)

Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma
por: Flores-Téllez, Teresita N. J., et al.
Publicado: (2015)

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming
por: Liu, Yang, et al.
Publicado: (2019)

Bidirectional Tumor-Promoting Activities of Macrophage Ezrin
por: Khan, Krishnendu, et al.
Publicado: (2020)

Expression of ezrin protein and phosphorylated ezrin in pelvic endometriotic lesions
por: Peloggia, Alessandra, et al.
Publicado: (2022)

Role of phospho–ezrin in differentiating thyroid carcinoma
por: Lathika, Lakshmi Mohan, et al.
Publicado: (2019)

Glycolytic Reprogramming in Silica-Induced Lung Macrophages and Silicosis Reversed by Ac-SDKP Treatment
por: Mao, Na, et al.
Publicado: (2021)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
por: Xu, Kangdi, et al.
Publicado: (2022)

NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer
por: Chen, Xiaona, et al.
Publicado: (2023)

Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
por: Liu, Jia, et al.
Publicado: (2020)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

Mechanisms Underlying Cancer Progression Caused by Ezrin Overexpression in Tongue Squamous Cell Carcinoma
por: Saito, Shota, et al.
Publicado: (2013)

Targeting WDxR motif reprograms immune microenvironment and inhibits hepatocellular carcinoma progression
por: Zhang, Heng, et al.
Publicado: (2023)

uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines
por: Biagioni, Alessio, et al.
Publicado: (2020)

PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
por: Dou, Qianhui, et al.
Publicado: (2022)

Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
por: Pourbaghi, Miles, et al.
Publicado: (2023)

The IRE1α-XBP1 Signaling Axis Promotes Glycolytic Reprogramming in Response to Inflammatory Stimuli
por: English, Bevin C., et al.
Publicado: (2022)

Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis
por: Mackenzie, Jared S., et al.
Publicado: (2020)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i5p2rj3u9eqrgvbfnhfmlulnil